Finally, a sign of life for MedHab appeared on the web. It came from the University of Texas-Arlington's Research Institute and their recently released strategic plan:
Biomedical Technologies
UTARI’S Biomedical Technologies Division focuses on developing clinically relevant devices and systems that can be utilized by health care providers as well as patients to enhance diagnostics, treatment, rehabilitation, and assisted living. Based on our core technologies and expertise, we are focusing on the following broad areas: tissue regeneration and wound healing, diagnostics, drug delivery, assistive and preventive care, remote monitoring and telemedicine, rehabilitation, pandemic and bio-threat detection, and medical training and research systems. UTARI is able to work with partners on projects at any stage in order to transition basic research to prototypes to low volume production for clinical trials.
Strategic Partners
Our current partners include the Feinberg School of Medicine at Northwestern University, the Institute of Surgical Research at US Army Dental and Trauma Research Detachment, the McGowan Institute for Regenerative Medicine at University of Pittsburg, the Georgia Institute of Technology, the South Carolina Research Association, Dartmouth University, Dallas Veteran Affairs, the University of North Texas Health Science Center, UT Southwest Medical Center, Texas Health Resources, Ampcare, and MedHab.
Will the next sign come from the Standard Times, Angelo State or the City of San Angelo? The City has a Strategic Planning session set for February 26. Will the session be Medhabulous?
No comments:
Post a Comment